IMMUNOCELLULAR THERAPEUTICS LTD Common Stock

YTD

ALL

Why Robinhood?

You can watch IMUC and buy or sell other stocks, ETFs, and their options commission-free!

About IMUC

ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells.

CEO

Anthony J. Gringeri, PhD

CEOAnthony J. Gringeri, PhD

Employees

—

Employees—

Headquarters

Westlake Village, California

HeadquartersWestlake Village, California

Founded

2006

Founded2006

Employees

—

Employees—

IMUC Key Statistics

Market cap

1.30M

Market cap1.30M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

5.57K

Average volume5.57K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.20

52 Week high$3.20

52 Week low

$0.161

52 Week low$0.161